生物标志物 生物标志物
Hannah Le1,2, Roger Raymond2, Neil Vasdev1,2
1University of Toronto, Toronto, ON, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
阿尔茨海默氏病 (AD) 的大脑显示突触囊糖蛋白2A (SV2A) 和纯能受体P2Y12R的减少,以及tau的增加. 这些变化相互关联,为AD进展和潜在的成像生物标志物提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 阿尔茨海默氏症疾病研究研究
背景情况:
- 阿尔茨海默病 (AD) 具有复杂的神经病理变化的特征.
- 突触囊糖蛋白2A (SV2A),纯能受体P2Y12R和高酸化是阿尔茨海默氏症研究中的关键目标.
- 了解SV2A,P2Y12R和tau之间的相互作用对于推动AD诊断和治疗至关重要.
研究的目的:
- 为了研究SV2A,P2Y12R和tau在阿尔茨海默病患者和认知正常对照 (CN) 的死后脑组织中的表达和分布.
- 评估AD大脑中SV2A ([3H]UCB-J),P2Y12R ([3H]PSB-0413) 和tau ([18F]MK-6240) 的放射追踪剂的结合之间的相关性.
主要方法:
- 在体外自发放射 (ARG) 使用特定的放射追踪物 ([3H]PSB-0413, [3H]UCB-J, [18F]MK-6240) 在死后的海马和脑内皮层组织上.
- 使用数字ARG对放射性追踪剂结合的量化和非特异性结合的确定.
- 对阿尔茨海默病患者的区域数据进行了绑定相关性分析.
主要成果:
- [3H]PSB-0413 (P2Y12R) 的结合降低在AD患者的脑内皮层 (SUB) 和脑内皮层 (EC) 中被观察到,与CN相比.
- [3H]UCB-J (SV2A) 结合在阿尔茨海默病患者的牙状 (DG),CA1和EC中显著减少.
- [18F]MK-6240结合 (tau) 在AD患者的CA1和SUB区域增加,与tau总量局部化一致.
- 在AD大脑中发现了 [3H]UCB-J, [3H]PSB-0413 和 [18F]MK-6240 的区域结合之间的显著正相关性.
结论:
- 在AD大脑中,SV2A水平下降,tau积累增加,P2Y12R表达减少.
- 这些发现与SV2A和tau的体内人体PET成像研究一致.
- 观察到的相关性表明,在AD进展中,突触密度,微质激活和病理之间存在潜在的联系.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516